Kulisevsky, Jaime

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 2,609

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., et al. (2019) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 2,454

Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Pagonabarraga, J., Martinez‐Horta, S., Fernández de Bobadilla, R., Pérez, J., Ribosa‐Nogué, R., Marín, J., Pascual‐Sedano, B., García, C., Gironell, A., & Kulisevsky, J. (2016) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 236

The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study

Mårtensson, G., Ferreira, D., Granberg, T., Cavallin, L., Oppedal, K., Padovani, A., Rektorova, I., Bonanni, L., Pardini, M., Kramberger, M. G., et al. (2020) · Medical Image Analysis

Dementia and Cognitive Impairment ResearchDomain Adaptation and Few-Shot Learning

Cited by 176

Understanding visual hallucinations: A new synthesis

Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience & Biobehavioral Reviews

Hallucinations in medical conditionsVisual perception and processing mechanisms

Cited by 83

Parkinson disease psychosis: from phenomenology to neurobiological mechanisms

Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S., & Kulisevsky, J. (2024) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 69

Routine neurophysiologic tremor analysis as a diagnostic tool for essential tremor: a prospective study

Gironell, A., Kulisevsky, J., Pascual-Sedano, B., & Barbanoj, M. (2004) · Journal of Clinical Neurophysiology

Deep Brain Stimulation and Movement DisordersMotor Control and Adaptation

Cited by 59

Review: Diagnosis and management of essential tremor and dystonic tremor

Gironell, A., & Kulisevsky, J. (2009) · Therapeutic Advances in Neurological Disorders

Deep Brain Stimulation and Movement DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 41

Connectome-based brain fingerprints predict early cognitive decline in Parkinson’s patients with minor hallucinations

Stampacchia, S., Bernasconi, F., Van De Ville, D., Amico, E., Pagonabarraga, J., Kulisevsky, J., & Blanke, O. (2025) · bioRxiv (Cold Spring Harbor Laboratory)

Functional Brain Connectivity StudiesParkinson's Disease Mechanisms and Treatments

Cited by 5